Anti-cholesterol statins don’t revoke cancer risk: study

<p>(Reuters) – Despite progressing indications that people holding cholesterol-lowering <span>statins</span> competence have a reduced risk of building <span>melanoma</span>, a investigate of thousands of women found that a renouned drugs do zero to forestall a fatal <span>skin cancer</span>.</p>
<p> Evidence from experiments on cells and one hearing in people had suggested some of a same properties of statins that strengthen opposite heart illness competence also forestall melanoma, a many fatal form of skin cancer.</p>
<p> But researchers led by <span>Michael Simon</span>, during <span>Karmanos Cancer Institute</span> in Detroit, found no impact on cancer in women who took a drugs, that embody atorvastin and pravastatin, to reduce their cholesterol.</p>
<p> “I don’t consider there’s anything here that suggests statins competence be protecting fo...